Kymera Therapeutics, Inc. (NASDAQ:KYMR) Director Sells $280,415.00 in Stock

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) Director Joanna Horobin sold 8,500 shares of the stock in a transaction on Friday, June 7th. The shares were sold at an average price of $32.99, for a total value of $280,415.00. The sale was disclosed in a filing with the SEC, which is available through the […]

Related Keywords

California ,United States ,Piper Sandler ,Stifel Nicolaus ,Dekabank Deutsche Girozentrale ,Joanna Horobin ,Comerica Bank ,Virtu Financial ,Nasdaq ,Kymera Therapeutics Inc ,Artal Group ,Jpmorgan Chase Co ,Kymera Therapeutics ,Get Free Report ,Director Joanna Horobin ,Bank Deutsche Girozentrale ,California State Teachers Retirement System ,State Teachers Retirement System ,Kymera Therapeutics Daily ,